Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Grassley Wants FDA To Give More Info To CMS, Cites Menaflex Case

This article was originally published in The Gray Sheet

Executive Summary

Controversy over FDA's 2008 clearance of ReGen Biologics' Menaflex knee repair device has now expanded into questions from Congress over how effectively FDA shares information with its sister agency CMS

You may also be interested in...



FDA And CMS Agree To Share Data Routinely In Step Toward Parallel Reviews

Routine sharing of data between FDA and CMS will be possible for the first time under a June 23 memorandum of understanding that could serve as a first step toward parallel reviews for marketing approval and Medicare coverage

FDA And CMS Agree To Share Data Routinely In Step Toward Parallel Reviews

Routine sharing of data between FDA and CMS will be possible for the first time under a June 23 memorandum of understanding that could serve as a first step toward parallel reviews for marketing approval and Medicare coverage

Next Carotid Stenting Coverage Request Could Come This Summer

A cardiology group says it will make a formal request to expand coverage for carotid artery stenting after new consensus clinical guidelines are issued this summer incorporating data from the just-published CREST trial

Related Content

Topics

UsernamePublicRestriction

Register

OM006550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel